A prospective multisite trial is being organized to test whether GLP-1 therapy can lower breast cancer incidence in high-risk women
Kidney function tests: your eGFR and creatinine levels should be checked every 3-4 months initially, rather than the usual 6-12 months for stable CKD Hydration status: regular assessment for signs of dehydration, particularly during the first few months when nausea is most common Blood pressure monitoring: weekly home blood pressure checks, as your medication needs may change with weight loss Electrolyte levels: sodium, potassium, and other electrolytes should be monitored more frequently, particularly if you experience significant nausea or reduced appetite Medication review: regular assessment of all your medications, as doses may need adjusting with weight loss and changing kidney function Cardiovascular risk factors: CKD increases heart disease risk, so lipid (fat) and diabetes markers need monitoring alongside kidney function Your GP should coordinate this monitoring with your kidney specialist
Spiering BA, Kraemer WJ, Vingren JL, Hatfield DL, Fragala MS, Ho JY, Maresh CM, Anderson JM, Volek JS
What Causes a Cyst
This step prevents introducing bacteria or contaminants into either vial
